Regeneron Pharmaceuticals Inc 2023 Sustainability Report
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2023
Type: Sustainability Report
Pages: 70
The report describes the company's 2023 double materiality assessment, a 42% reduction in combined Scope 1 and 2 market-based emissions intensity, 22% renewable electricity, and reductions in water use and waste generation. It also reports a global workforce of 13,450 colleagues and limited assurance over selected ESG data.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.